These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36876764)

  • 1. The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics.
    Eilts F; Bauer S; Fraser K; Dordick JS; Wolff MW; Linhardt RJ; Zhang F
    Carbohydr Polym; 2023 Jan; 299():120167. PubMed ID: 36876764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
    He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
    Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spike-heparan sulfate interactions in SARS-CoV-2 infection.
    Kearns FL; Sandoval DR; Casalino L; Clausen TM; Rosenfeld MA; Spliid CB; Amaro RE; Esko JD
    Curr Opin Struct Biol; 2022 Oct; 76():102439. PubMed ID: 35926454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation.
    Zhang Q; Tang W; Stancanelli E; Jung E; Syed Z; Pagadala V; Saidi L; Chen CZ; Gao P; Xu M; Pavlinov I; Li B; Huang W; Chen L; Liu J; Xie H; Zheng W; Ye Y
    Nat Commun; 2023 Sep; 14(1):5777. PubMed ID: 37723160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from
    Song Y; He P; Rodrigues AL; Datta P; Tandon R; Bates JT; Bierdeman MA; Chen C; Dordick J; Zhang F; Linhardt RJ
    Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
    Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
    Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
    Wang X; Bie L; Gao J
    J Chem Inf Model; 2022 Feb; 62(3):656-667. PubMed ID: 35060381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions.
    Kwon PS; Xu S; Oh H; Kwon SJ; Rodrigues AL; Feroz M; Fraser K; He P; Zhang F; Hong JJ; Linhardt RJ; Dordick JS
    Commun Biol; 2023 Apr; 6(1):387. PubMed ID: 37031303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
    Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
    Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.
    Yue J; Jin W; Yang H; Faulkner J; Song X; Qiu H; Teng M; Azadi P; Zhang F; Linhardt RJ; Wang L
    Front Mol Biosci; 2021; 8():649575. PubMed ID: 34179075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
    McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2.
    Pavan M; Fanti CD; Lucia AD; Canato E; Acquasaliente L; Sonvico F; Delgado J; Hicks A; Torrelles JB; Kulkarni V; Dwivedi V; Zanellato AM; Galesso D; Pasut G; Buttini F; Martinez-Sobrido L; Guarise C
    Eur J Pharm Sci; 2023 Aug; 187():106489. PubMed ID: 37311533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SARS-CoV-2 wild-type (Wuhan-Hu-1) and Delta (B.1.617.2) strains by marine sulfated glycans.
    Dwivedi R; Sharma P; Farrag M; Kim SB; Fassero LA; Tandon R; Pomin VH
    Glycobiology; 2022 Sep; 32(10):849-854. PubMed ID: 35788318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
    Prieto-Fernández E; Egia-Mendikute L; Vila-Vecilla L; Bosch A; Barreira-Manrique A; Lee SY; García-Del Río A; Antoñana-Vildosola A; Jiménez-Lasheras B; Moreno-Cugnon L; Jiménez-Barbero J; Berra E; Ereño-Orbea J; Palazon A
    Emerg Microbes Infect; 2021 Dec; 10(1):1065-1076. PubMed ID: 34013835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.
    Watanabe T; Takeda K; Hiemori K; Minamisawa T; Tateno H
    FEBS Lett; 2021 Sep; 595(18):2341-2349. PubMed ID: 34375459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin.
    Yang J; Song Y; Jin W; Xia K; Burnett GC; Qiao W; Bates JT; Pomin VH; Wang C; Qiao M; Linhardt RJ; Dordick JS; Zhang F
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.